相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Serum levels of ADAM12-S: possible association with the initiation and progression of dermal fibrosis and interstitial lung disease in patients with systemic sclerosis
T. Taniguchi et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2013)
Decreased cathepsin V expression due to Fli1 deficiency contributes to the development of dermal fibrosis and proliferative vasculopathy in systemic sclerosis
Shinji Noda et al.
RHEUMATOLOGY (2013)
A possible contribution of visfatin to the resolution of skin sclerosis in patients with diffuse cutaneous systemic sclerosis via a direct anti-fibrotic effect on dermal fibroblasts and Th1 polarization of the immune response
Yuri Masui et al.
RHEUMATOLOGY (2013)
Overexpression of CXCL5 Mediates Neutrophil Infiltration and Indicates Poor Prognosis for Hepatocellular Carcinoma
Shao-Lai Zhou et al.
HEPATOLOGY (2012)
Serum Levels of Galectin-3: Possible Association with Fibrosis, Aberrant Angiogenesis, and Immune Activation in Patients with Systemic Sclerosis
Takashi Taniguchi et al.
JOURNAL OF RHEUMATOLOGY (2012)
Serum adiponectin levels inversely correlate with the activity of progressive skin sclerosis in patients with diffuse cutaneous systemic sclerosis
Y. Masui et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2012)
A Possible Contribution of Altered Cathepsin B Expression to the Development of Skin Sclerosis and Vasculopathy in Systemic Sclerosis
Shinji Noda et al.
PLOS ONE (2012)
Anti-CXCL5 therapy ameliorates IL-17-induced arthritis by decreasing joint vascularization
Sarah R. Pickens et al.
ANGIOGENESIS (2011)
Endothelial Fli1 Deficiency Impairs Vascular Homeostasis A Role in Scleroderma Vasculopathy
Yoshihide Asano et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Mechanisms in the loss of capillaries in systemic sclerosis: angiogenesis versus vasculogenesis
Mirko Manetti et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
Future treatments in systemic sclerosis
Yoshihide Asano
JOURNAL OF DERMATOLOGY (2010)
Bronchoalveoloar lavage fluid cytokines and chemokines as markers and predictors for the outcome of interstitial lung disease in systemic sclerosis patients
Katrin Schmidt et al.
ARTHRITIS RESEARCH & THERAPY (2009)
Capillary Regeneration in Scleroderma: Stem Cell Therapy Reverses Phenotype?
Jo N. Fleming et al.
PLOS ONE (2008)
Transforming growth factor-β regulates DNA binding activity of transcription factor fli1 by p300/CREB-binding protein-associated factor-dependent acetylation
Yoshihide Asano et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Topical antisense oligonucleotide therapy against LIX, an enterocyte-expressed CXC chemokine, reduces murine colitis
JH Kwon et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2005)
Elevated matrix metalloproteinase-9 in patients with systemic sclerosis
WU Kim et al.
ARTHRITIS RESEARCH & THERAPY (2005)
Chemokine-cytokine cross-talk -: The ELR+ CXC chemokine LIX (CXCL5) amplifies a proinflammatory cytokine response via a phosphatidylinositol 3-kinase-NF-κB pathway
B Chandrasekar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)